Case Report
Incidental Eosinophilic Chromophobe Renal Cell Carcinoma in Renal Allograft
Table 1
Primary antibodies used for IHC, their clone, dilution, and source.
| Antibody | Clone | Dilution | Source |
| Pan CK | AE1/AE3 | 1/100 | Cell Marque, CA, USA | CK8/18 | TSIFB5 | RTU | Ventana, AZ, USA | CK7 | OV-TL12/30 | 1 : 50 | Cell Marque | EMA | E29 | 1 : 50 | Cell Marque | E-Cadherin | NCH-38 | 1 : 50 | Cell Marque | RCC | SPM314 | 1 : 20 | Dako, Denmark | Vimentin | V9 | 1 : 300 | Dako | CD10 | 56C6 | RTU | Ventana | CD117 (C-KIT) | YR145 | 1 : 400 | Cell Marque |
|
|
CK, cytokeratin; RTU, Ready to Use; EMA, epithelial membrane antigen; RCC, renal cell carcinoma.
|